Status | Study |
Recruiting |
Study Name: Alipogene Tiparvovec for the Treatment of LPLD Patients Condition: LPL Deficiency Date: 2016-05-10 Interventions: Drug: alipogene tiparvovec A d |
Recruiting |
Study Name: Orlistat for the Treatment of Type I Hyperlipoproteinemia Condition: Hyperlipoproteinemia Type I Hypertriglyceridemia Date: 2016-05-02 Interventions: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei |
Recruiting |
Study Name: The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome Lipopro Date: 2016-01-12 Interventions: Drug: Volanesorsen 300 mg volanesorsen Other Names: |
Not yet recruiting |
Study Name: Lipoprotein Lipase Enzyme Activity Assay Validation and Clinical Assessment Condition: Lipoprotein Lipase Deficiency Date: 2016-01-12 Interventions: Drug: Heparin Participants will be given IV heparin in order to release lipoprotein lipase from capillar |
Completed |
Study Name: The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome Date: 2014-08-05 Interventions: Drug: volanesorsen Other Names |
Completed |
Study Name: Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia Condition: Lipoprotein Lipase Deficiency, Familial H Date: 2014-03-24 Interventions: Drug: CAT-2003 Drug: Placebo |
Terminated |
Study Name: Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I) Date: 2012-04-27 Interventions: Drug: LCQ908 |
Completed |
Study Name: A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome Condition: Familial Chylomicronemia Syndrome (FCS) Date: 2011-12-21 Interventions: Drug: LCQ908 LCQ908 10 mg, LCQ |
Completed |
Study Name: Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies Condition: Lipoprotein Lipase Deficiency Date: 2011-10-03 |
Terminated |
Study Name: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Condition: Hyperlipoproteinemia Type I Date: 2011-09-28 |